Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.400.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.400.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.400.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.400.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.537NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.537NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4625.82China
B.1.537NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.537NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-22126.5Thailand
B.1.537NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.537NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
B.1.537NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.537NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.537NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F1059.37US
B.1.537NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-5669.88US
B.1.537NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-1648.07Singapore
B.1.537NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.537NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-2619.71Germany
B.1.537NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-5370.98Germany
B.1.537NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-3484.59South Korea
B.1.537NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.537NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.537NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.537NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.537NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.537NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.537NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.537NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.537NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.548NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
B.1.548NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
B.1.548NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.548NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-22126.5Thailand
B.1.548NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.548NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
B.1.548NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.548NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.548NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.548NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
B.1.548NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.548NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.548NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.548NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-3342.44Germany
B.1.548NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.548NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.548NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.548NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.548NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.548NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.548NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.548NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used